Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $894,247 - $1.46 Million
-3,960 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $878,724 - $1.92 Million
3,960 New
3,960 $1.52 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Central Asset Investments & Management Holdings (Hk) LTD Portfolio

Follow Central Asset Investments & Management Holdings (Hk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Asset Investments & Management Holdings (Hk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Central Asset Investments & Management Holdings (Hk) LTD with notifications on news.